InvestorsHub Logo
Followers 51
Posts 9104
Boards Moderated 1
Alias Born 10/25/2007

Re: subslover post# 10

Thursday, 11/10/2022 8:33:25 AM

Thursday, November 10, 2022 8:33:25 AM

Post# of 89
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Nov 10, 2022

https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-reports-third-quarter-2022-financial-results



On December 6, the Company will hold its virtual R&D Day with leadership and renowned oncology experts to present an in-depth overview of the Company’s viral immunotherapy platforms and clinical pipeline including additional data from its phase 2 clinical trial of CAN-2409 in combination with anti-PD-1 or PD-L1 agents in patients with stage III/IV non-small cell lung cancer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CADL News